Ariane K Kawata1, Hilary Wilson2, Siew Hwa Ong3, Karoly Kulich3, Karin Coyne2. 1. Outcomes Research, Evidera, 7101 Wisconsin Avenue Suite 1400, Bethesda, MD, 20814, USA. ariane.kawata@evidera.com. 2. Outcomes Research, Evidera, 7101 Wisconsin Avenue Suite 1400, Bethesda, MD, 20814, USA. 3. Novartis Pharma AG, Basel, Switzerland.
Abstract
AIMS: The aim of this study was to evaluate the factor structure and psychometric characteristics of the Hypoglycemia Perspectives Questionnaire (HPQ) assessing experience and perceptions of hypoglycemia in patients with type 2 diabetes mellitus (T2DM). METHODS: HPQ was administered to adults with T2DM in a clinical sample from Cyprus (HYPO-Cyprus, n = 500) and a community sample in the United States (US, n = 1257) from the 2011 US National Health and Wellness Survey. Demographic and clinical data were collected. Analysis of HPQ data from two convenience samples examined item performance, factor structure, and HPQ measurement properties (reliability, convergent validity, known-groups validity). RESULTS: Analyses supported three HPQ domains: symptom concern (six items), compensatory behavior (five items), and worry (five items). Internal consistency was high for all three domains (all ≥0.75), supporting reliability. Convergent validity was supported by moderate Spearman correlations between HPQ domain scores and the Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) total score. Patients with recent hypoglycemia events had significantly higher HPQ scores, supporting known-group validity. CONCLUSIONS: HPQ may be a valid and reliable measure capturing the experience and impact of hypoglycemia and useful in clinical trials and community-based settings.
AIMS: The aim of this study was to evaluate the factor structure and psychometric characteristics of the Hypoglycemia Perspectives Questionnaire (HPQ) assessing experience and perceptions of hypoglycemia in patients with type 2 diabetes mellitus (T2DM). METHODS:HPQ was administered to adults with T2DM in a clinical sample from Cyprus (HYPO-Cyprus, n = 500) and a community sample in the United States (US, n = 1257) from the 2011 US National Health and Wellness Survey. Demographic and clinical data were collected. Analysis of HPQ data from two convenience samples examined item performance, factor structure, and HPQ measurement properties (reliability, convergent validity, known-groups validity). RESULTS: Analyses supported three HPQ domains: symptom concern (six items), compensatory behavior (five items), and worry (five items). Internal consistency was high for all three domains (all ≥0.75), supporting reliability. Convergent validity was supported by moderate Spearman correlations between HPQ domain scores and the Audit of Diabetes-Dependent Quality of Life (ADDQoL-19) total score. Patients with recent hypoglycemia events had significantly higher HPQ scores, supporting known-group validity. CONCLUSIONS:HPQ may be a valid and reliable measure capturing the experience and impact of hypoglycemia and useful in clinical trials and community-based settings.
Authors: J Speight; S M Barendse; H Singh; S A Little; B Inkster; B M Frier; S R Heller; M K Rutter; J A M Shaw Journal: Diabet Med Date: 2015-07-14 Impact factor: 4.359
Authors: Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati Journal: Lancet Date: 2011-06-24 Impact factor: 79.321
Authors: Domingo Orozco-Beltrán; Sara Artola; Margarida Jansà; Martin Lopez de la Torre-Casares; Eva Fuster Journal: Health Qual Life Outcomes Date: 2018-03-23 Impact factor: 3.186
Authors: Caroline B Terwee; Petra J M Elders; Marlous Langendoen-Gort; Ellen B M Elsman; Cecilia A C Prinsen; Amber A van der Heijden; Maartje de Wit; Joline W J Beulens; Lidwine B Mokkink; Femke Rutters Journal: Curr Diab Rep Date: 2022-07-11 Impact factor: 5.430